Parties d'ouvrages collectifs (2)
  1. 1. Ando, K., Laborde, Q., Brion, J. P., & Duyckaerts, C. (2018). 3-D imaging in post-mortem human brain with CLARITY and CUBIC. In I. Huitinga & M. Webster (Eds.), 3D imaging in the postmortem human brain with CLARITY and CUBIC, Vol. 150. Brain Banking in Neurologic and Psychiatric Diseases (pp. 303-317). Elsevier.(Handbook of Clinical Neurology). doi:10.1016/b978-0-444-63639-3.00021-9
  2. 2. Ando, K. (2014). Alzheimer risk factor, PICALM is involved in tau pathology in Alzheimer and other tauopathies. In Psychiatry Today (p. 15). Tokyo, Japan: Haruyoshi Kato.
    3.   Articles dans des revues avec comité de lecture (53)
  3. 1. Nagaraj, S., Quintanilla Sanchez, C., Ando, K., López Gutiérrez, L., Gansemans, Y., Doeraene, E., Kosa, A.-C., Aydin, E., Van Nieuwerburgh, F., Brion, J. P., & Leroy, K. (2026). Differentially expressed miRNAs in the temporal cortex of Alzheimer's disease patients and their association to tau pathology. Communications Biology, 9(1), 253. doi:10.1038/s42003-026-09530-0
  4. 2. Ando, K., López Gutiérrez, L., Mansour, S., Yilmaz, Z., Dauphinot, L., Verheijen, J., Fontaine, G., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Nagaraj, S., Kosa, A.-C., Watanabe, T., Sleegers, K., Potier, M.-C., Brion, J. P., & Leroy, K. (2026). PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer’s Disease. Cells, 15(3), 235. doi:10.3390/cells15030235
  5. 3. Riku, Y., Brion, J. P., Ando, K., Uchihara, T., & Iwasaki, Y. (2025). The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity? International journal of molecular sciences, 26(24). doi:10.3390/ijms262412088
  6. 4. Ramos, A. R., Bregni, G., Gillet, N., Ando, K., Bodart, C., Vercauteren Drubbel, A., Descampe, L., Moresi, F., Bisteau, X., Verheye, Q., Pirard, S., Erneux, C., & Beck, B. (2025). SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma. Molecular cancer.
  7. 5. Kosa, A.-C., López Gutiérrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet-Depauw, A., Pieters, K., Van Morckhoven, D., Imbault, V., Dubois, C., Bisteau, X., Stamatopoulos, B., Igoillo Esteve, M., Brion, J. P., & Leroy, K. (2025). Differential effects of age and sex on tau pathology propagation in the htau mouse model: a neuropathological and proteomic study. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(1), e70784. doi:doi.org/10.1002/alz.70784
  8. 6. Ando, K., Htut Thazin, M., Antonelli, E. M., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Nagaraj, S., Ramos, A. R., Coulonval, K., Roger, P. P., Brion, J. P., & Leroy, K. (2025). Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer’s Disease: Implications for Autophagy Dysfunction. International journal of molecular sciences, 26(12), 5827. doi:10.3390/ijms26125827
  9. 7. Ando, K., Kosa, A.-C., Mehadji, Y., Lasri, H., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Doeraene, E., Wathelet-Depauw, A., Nagaraj, S., Brion, J. P., & Leroy, K. (2025). Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model. Biomolecules, 15(2), doi.org/10.3390/biom15020159, 159.
  10. 8. Nagaraj, S., Quintanilla Sanchez, C., Ando, K., López Gutiérrez, L., Doeraene, E., Kosa, A.-C., Aydin, E., Brion, J. P., & Leroy, K. (2024). Downregulation of hsa-miR-132 and has-miR129: non-coding RNA molecular signatures of Alzheimer's disease. Frontiers in Molecular Neuroscience, 17(2), 10.3389/fnmol.2024.1423340.
  11. 9. Ando, K., Küçükali, F., Doeraene, E., Nagaraj, S., Antonelli, E. M., Htut Thazin, M., Yilmaz, Z., Kosa, A.-C., López Gutiérrez, L., Quintanilla Sanchez, C., Aydin, E., Ramos, A. R., Mansour, S., Turbant, S., Schurmans, S., Sleegers, K., Erneux, C., Brion, J. P., & Leroy, K. (2024). Alteration of gene expression and protein solubility of the PI5- phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression. Acta Neuropathologica, 147(94), 10.1007/s00401-024-02745-7.
  12. 10. Ando, K., Nagaraj, S., Küçükali, F., De Fisenne, M.-A., Kosa, A.-C., Doeraene, E., López Gutiérrez, L., Brion, J. P., & Leroy, K. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells, 11(24), 3994. doi:10.3390/cells11243994
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>